Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Non-Muscle Invasive Bladder Neoplasms × Mitomycin × Clear all

Phase

Phase 3 12 Phase 2 3 Phase 1/2 2 Phase EARLY_PHASE1 1 Phase 4 1 Phase 2/3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Anus Neoplasms 2 Virus Diseases 1 Urinary Bladder Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma in Situ 1 Adenoviridae Infections 1

Interventions

apaziquone 1 Mitomycin 1 Interferon-alpha 1 BCG Vaccine 1 ALT-803 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01920269 2013-08-09

EMDA/MMC

University of Rome Tor Vergata

Phase 2/3 Completed

Non-Muscle Invasive Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡